A. Norrbyteglund et al., RELATION BETWEEN LOW CAPACITY OF HUMAN SERA TO INHIBIT STREPTOCOCCAL MITOGENS AND SERIOUS MANIFESTATION OF DISEASE, The Journal of infectious diseases, 170(3), 1994, pp. 585-591
The proliferative response of lymphocytes induced by a new streptococc
al mitogenic factor (MF) and the streptococcal pyrogenic exotoxins (Sp
e) A and B was determined in sera from 6 healthy persons. Responses we
re compared to those obtained from reference serum that lacked mitogen
-specific ELISA antibodies. The sera showed individual variations in t
he levels of MF-and Spe-specific antibodies, as determined by ELISA. T
he experiments showed that most human sera, which contained mitogen-sp
ecific antibodies, could neutralize the mitogenicity of the proteins.
However, there were sera that contained mitogen-specific antibodies bu
t that did not inhibit the toxin-induced proliferation. Thus, the ELIS
A antibody titer did not always equal the neutralizing capacity. Sera
from 27 patients with group A streptococcal bacteremia had significant
ly lower neutralizing ability against MF and SpeB than did sera from 2
5 uncomplicated tonsillitis cases.